Work

Second-line prescribing preferences of U.S. hematology-oncology physicians for patients (pts) with recurrent multiple myeloma (MM): Impact of novel agents.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.8061

Authors: Robert Z. Orlowski, Joanne P. Willey, Maria L. Lankford, Arden Buettner, Stewart Kaufman, Susan Lynne Britton, Mitchell Scharf, Brynn Tiscione, Doug B. Neely, Joel H. Schwartz

Institutions: The University of Texas MD Anderson Cancer Center, Massachusetts General Hospital

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891257036

Cites:

Cited by:

Related to: 10